Monday, June 15, 2026

How eBay eGS Boosted Korean Sellers’ Exports to the U.S. by 60% in 2025

Korean sellers' shipments to the U.S. surged 60% despite trade barriers, driven by strong dollar and improved shipping solutions.

Uncovering the Truth: The Controversial 8 Million USD North Korea Fund Transfer Explained

The People Power Party criticizes the Democratic Party's claims regarding North Korean remittances linked to Governor Lee Jae Myung as misinformation.

Embassy in Russia: ‘No South Korean Casualties Reported in the Shooting at a Russian Concert Hall’

Regarding the massive shooting and fire incident...

Tag: Cartistem

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

CARTISTEM vs. Traditional Treatments: What Makes Medipost’s Stem Cell Therapy a Game-Changer?

Medipost to commercialize CARTISTEM in Japan using domestically produced media, enhancing supply chain stability and competitiveness.

Medipost Reports Positive Phase 3 Results for CARTISTEM in Japan’s Knee Osteoarthritis Trial

Medipost's CARTISTEM therapy shows significant efficacy in Phase 3 trials for knee osteoarthritis in Japan, enhancing global competitiveness.

Medipost’s CARTISTEM® Completes Phase 3 Trials in Japan: What This Means for Knee Osteoarthritis Treatment

Medipost completes Phase 3 trial for CARTISTEM in Japan, targeting knee osteoarthritis treatment and planning U.S. trial enrollment soon.

Medipost’s Cartistem: Achieving 3000 Knee Cartilage Restoration Surgeries – A Game Changer for Osteoarthritis Treatment

Medipost's Cartistem therapy reaches 3,000 procedures for cartilage restoration, proving its safety and efficacy for knee osteoarthritis.

U.S. Surgeons Get Hands-On With Korea’s Game-Changing Stem Cell Therapy

Medipost's Cartistem® training program for U.S. orthopedic specialists enhances global collaboration and prepares for Phase 3 trials.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.